MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (L36186) - Retirement - Effective August 17, 2025

Date Posted: August 21, 2025

This Local Coverage Determination (LCD) has been retired under contractor numbers: 02101 (AK), 02201 (ID), 02301 (OR), 02401 (WA), 03101 (AZ), 03201 (MT), 03301 (ND), 03401 (SD), 03501 (UT), and 03601 (WY).

Medicare Coverage Database (MCD) Number: L36186

Effective Date: August 17, 2025

Rationale: L36186 MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease and A57422 Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease will be retired on 8/17/2025 because the information in the LCD and article have been incorporated within the MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms L39923 LCD and related article.

Visit the Retired LCDs webpage to access the retired LCDs.

Last Updated Aug 20 , 2025